Series F https://www.bioworld.com/rss en-us Rakuten closes $100M series F round, teams with Lotte Biologics http://www.bioworld.com/articles/728054 Tue, 20 Jan 2026 11:00:00 -0500 https://www.bioworld.com/articles/728054-rakuten-closes-100m-series-f-round-teams-with-lotte-biologics Rakuten (From left) Rakuten Medical COO Abhijit Bhatia, Rakuten Medical President Minami Maeda, Lotte Biologics co-CEOs James Park and Shin Yoo-yeol sign a manufacturing partnership at the J.P. Morgan 2026 Healthcare Conference in San Francsico. Credit: Lotte Biologics Glooko raises $100M, appoints new CEO http://www.bioworld.com/articles/712943 Thu, 10 Oct 2024 12:00:00 -0400 https://www.bioworld.com/articles/712943-glooko-raises-100m-appoints-new-ceo Glooko platform on desktop, smartphone Glooko Inc.’s diabetes management platform. Route 92 raises $50M in series F extension http://www.bioworld.com/articles/712452 Mon, 23 Sep 2024 12:00:00 -0400 https://www.bioworld.com/articles/712452-route-92-raises-50m-in-series-f-extension Route 92 Medical Snake Tenzing-7 and FC70-1 Route 92’s Freeclimb 70 reperfusion system. Credit: Route 92 Medical Inc. Vitalconnect shows lively growth, raises $30M http://www.bioworld.com/articles/699053 Wed, 19 Jul 2023 12:00:00 -0400 https://www.bioworld.com/articles/699053-vitalconnect-shows-lively-growth-raises-30m Vitalconnect Vitalconnect's Vitalpatch biosensor Bain pumps $215M into Heartflow as series F lead investor http://www.bioworld.com/articles/695862 Thu, 06 Apr 2023 13:00:00 -0400 https://www.bioworld.com/articles/695862-bain-pumps-215m-into-heartflow-as-series-f-lead-investor Fractyl nabs $100M to advance device for reducing insulin dependence http://www.bioworld.com/articles/508311 Wed, 16 Jun 2021 13:00:00 -0400 https://www.bioworld.com/articles/508311-fractyl-nabs-100m-to-advance-device-for-reducing-insulin-dependence Dollar sign in lightbulb Insightec aims for $150M in series F round http://www.bioworld.com/articles/433595 Mon, 09 Mar 2020 12:00:00 -0400 https://www.bioworld.com/articles/433595-insightec-aims-for-150m-in-series-f-round 3-9-Insightec-MRI.png Exablate Neuro. Credit: Insightec Ltd.